James Telfser s Top Picks: April 20, 2021
Morgan Stanley joins bank bond bonanza with three-part sale
John Zechner s Top Picks: April 19, 2021
Teslaâs fiery crash adds to drag on already wobbly EV stocks
An ether ETF isn t even launched and already there is a fee war
Tech leads stock drop from record; dollar falls
Wall Street canât stop smashing records while pandemic lingers
Greg Newman s Top Picks: April 16, 2021
Family offices are targeting 800% returns with SPAC economics
Ark Invest s Cathie Wood thinks Shopify could be next Amazon
Christine Poole s Top Picks: April 15, 2021
Cooler heads prevailed (mostly) during COVID market mayhem: Survey
Coinbase rallies as Wall Street optimism bucks Bitcoinâs dip
Burglar Downloaded Porn During Break-In – NBC 7 San Diego
nbcsandiego.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcsandiego.com Daily Mail and Mail on Sunday newspapers.
J&J, other drugmakers go to trial in California in $50 billion case over deadly legacy of opioids
netscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from netscape.com Daily Mail and Mail on Sunday newspapers.
J&J, others face California trial over claims they fueled opioid epidemic By Nate Raymond
The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company s listing at the NYSE in New York
(Reuters) – Four drugmakers are set to face trial on Monday in a lawsuit by several large counties in California that are seeking more than $50 billion over claims the companies helped fuel an opioid epidemic by deceptively marketing addictive painkillers.
The case against Johnson & Johnson, Teva Pharmaceutical Industries Ltd, Endo International PLC and AbbVie’s Allergan unit is one of the thousands of lawsuits by states and local governments seeking to hold pharmaceutical companies responsible for the drug crisis.